Related Experiment Video
Updated: Aug 1, 2025

Intracranial Injection of Adeno-associated Viral Vectors
Published on: November 17, 2010
Adverse events following COVID-19 immunisation (AEFI) at a COVID-19 vaccination centre: An observational analytical
Vinita Shukla1, Beena Sachan1, Sugandha Jauhari2
1Department of Community Medicine, Dr. R.M.L.I.M.S, Lucknow, Uttar Pradesh, India.
Insights
COVID-19 vaccines are safe, with most adverse events following immunisation (AEFI) being minor reactions. Higher AEFI incidence was observed in older age groups, but comorbidities showed no association with severity.
Area of Science:
- Immunology
- Vaccinology
- Public Health
Background:
- Coronavirus disease 2019 (COVID-19) vaccination programs aim to reduce disease severity and transmission.
- Understanding adverse events following immunisation (AEFI) across different demographics is crucial for vaccine safety monitoring and public confidence.
Purpose of the Study:
- To determine the incidence and characteristics of AEFI in various age groups following COVID-19 vaccination.
- To assess the association between comorbidities and the occurrence or severity of AEFI.
Main Methods:
- An observational analytical study was conducted on 1002 participants who received two doses of a COVID-19 vaccine.
- Participants were categorized into three age groups: 18-44 years, 45-60 years, and over 60 years.
- Data on AEFI were collected via semi-structured questionnaires during home visits.
Main Results:
- The incidence of any AEFI was highest in the >60 years age group (31.9%), followed by 45-60 years (19.74%), and 18-44 years (15.17%).
- AEFI severity was greater in the 18-44 years group (66.1%) compared to the 45-60 years (30.67%) and >60 years groups.
- Fever and injection site pain/inflammation were the most frequently reported AEFI. No association was found between comorbidities and AEFI severity.
Conclusions:
- COVID-19 vaccines demonstrate a favorable safety profile, with predominantly minor and expected immunogenic reactions.
- The observed AEFI rates and types are consistent with general vaccine responses.
- High vaccine uptake across all recommended age groups is encouraged to mitigate the impact of COVID-19.
Objectives:
The aim of this study was to determine the adverse events following immunisation (AEFI) in various age groups after coronavirus disease 2019 (COVID-19) vaccination and assess the association of comorbidities with AEFI.
Methods:
An observational analytical study was conducted among the general population who had received both doses of the COVID-19 vaccine. A total of 389 participants from the 18-44 years age group, 380 participants from the 45-60 years age group and 373 participants from the 60 plus age group were enrolled in the study after verbal and written consent. Simple random sampling was used to select the study participant in each group. Home visits were made to fill out the semi-structured questionnaire for information regarding any adverse event following COVID-19 immunisation.
Results:
Overall, 31.9%, 19.74% and 15.17% of >60, 45-60 and 18-44 years, respectively, reported any AEFI after COVID-19 immunisation. The severity of AEFI was more among the 18-44 years age group (66.1%) followed by 45-60 years (30.67%) and less among the older one, that is, >60 years. Fever and pain with inflammation at the injection site were the most common AEFI reported after any dose. There was no association of comorbidity with the severity of AEFI.
Conclusion:
Since the AEFI reported are very less, most of them were of a minor type and were general immunogenic reactions of any vaccine. Hence the COVID-19 vaccines are very safe, and uptake should be high among all the recommended age groups to combat the severity of the COVID-19 disease.
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Vaccinations
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Types of Reports II: Incident or Occurrence Report
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Allergic Drug Reactions

